Zaritsky succeeds Jay Bolling, who becomes executive chairman
Holly Henry, previously chief medical officer at FCB Health, will oversee medical strategy in the newly created role.
Deborah Furey will lead the agency’s pilot of a new personalized marketing offering.
Millian, a former Sanofi and Merck executive, on marketing new therapies in the MS market.
Please login or register first to view this content.